Latest Share Chat

DIRECTOR DEALINGS: Hutchison China Chairman Buys 25,000 Shares

Mon, 13th Apr 2015 08:46

LONDON (Alliance News) - Hutchison China MediTech Limited Monday said Chairman Simon To bought 25,000 shares at a price of GBP14.215 per share Friday.

Following this transaction, To is beneficially interested in 152,000 shares, representing approximately 0.29% of the current issued share capital. To has purchased 108,000 shares since March 30.

Shares in the healthcare group were up 5.8% at 1,517.69 pence Monday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Related Shares

More News

24 Jun 2024 12:20

Hutchmed partner gets European approval for fruqintinib

(Sharecast News) - Hutchmed China announced on Monday that its partner Takeda has received approval from the European Commission for 'Fruzaqla', or fr...

24 Jun 2024 10:00

IN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla

Hutchmed (China) Ltd - Hong Kong-headquartered biopharmaceutical company - Notes that Takeda Pharmaceuticals Co Ltd received a notification from the E...

17 Jun 2024 10:32

Hutchmed celebrates "promising" results for sovleplenib in China

(Alliance News) - Hutchmed (China) Ltd on Monday said its phase 3 trial of sovleplenib showed "consistent benefits" in adults with autoimmune disorder...

17 Jun 2024 09:28

Hutchmed publishes positive sovleplenib trial results

(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Hae...

7 Jun 2024 18:13

IN BRIEF: Hutchmed (China) begins trial of menin inhibitor HMPL-506

Hutchmed (China) Ltd - Hong Kong-headquartered biopharmaceutical company - Says that it has initiated Phase I clinical trial of its menin inhibitor HM...